USPTO Grants Foundational Patent to Amferia for Antimicrobial Technology

The antimicrobial hydrogel rapidly kills all types of bacteria, including antimicrobial-resistant types, without harming the body. The technology will be applied to wound-care products for human and animal use … Swedish medical device startup Amferia AB has been granted a foundational patent by the US Patent and Trademark Office (USPTO) for an antimicrobial material based on an amphiphilic antimicrobial hydrogel. The company said it is now in the final development stage for wound-care applications and aims to launch the first product within the animal health sector during 2022 … read more